Brain amino acid concentrations and Ca2+-dependent release in intractable depression assessed antemortem.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Brain Research

• Publication date

  1989-08-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0006-8993(89)90600-8PMID 2570624
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Release of neuroactive substances: homocysteic acid as an endogenous agonist of the NMDA receptor

  2005cited by this paper
• Regional weight loss of the cerebral cortex and some subcortical nuclei in senile dementia of the Alzheimer type

  2004cited by this paper
• Serotoninergic innervation of the cat cerebral cortex

  1988cited by this paper
• Topographical distribution of neurochemical changes in Alzheimer's disease.

  1988cited by this paper
• Brain GABAA/benzodiazepine binding sites and glutamic acid decarboxylase activity in depressed suicide victims.

  1988cited by this paper
• Are post-mortem biochemical studies of human brain worthwhile?

  1988cited by this paper
• Biochemical Aspects of Therapy-Resistant Depression

  1988cited by this paper
• Neuroanatomical Studies of Major Affective Disorders

  1988cited by this paper
• Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2)

  1988cited by this paper
• Evidence of Glutamatergic Denervation and Possible Abnormal Metabolism in Alzheimer's Disease

  1988cited by this paper
• The dementia of Alzheimer's disease: an update.

  1987cited by this paper
• Alzheimer's disease: Glutamate depletion in the hippocampal perforant pathway zone

  1987cited by this paper
• Somatostatin content and release measured in cerebral biopsies from demented patients.

  1987cited by this paper
• Classification of GABA and benzodiazepine receptors

  1987cited by this paper
• 5-HT receptor binding in post-mortem brain from patients with affective disorder.

  1987cited by this paper
• Glutamic Acid as a Putative Transmitter of the Interhemispheric Corticocortical Connections in the Rat

  1986cited by this paper
• The selectivity of the reduction of serotonin S2 receptors in Alzheimer-type dementia.

  1986cited by this paper
• An initial analysis of the regional distribution of excitatory sulphur-containing amino acids in the rat brain.

  1986cited by this paper
• The cerebral cortical appearance in depressed subjects

  1986cited by this paper
• Neurotransmitters in the cerebral cortex.

  1986cited by this paper
• In Vitro Release of Endogenous Excitatory Sulfur‐Containing Amino Acids from Various Rat Brain Regions

  1986cited by this paper
• A postmortem study of amino acid neurotransmitters in Alzheimer's disease

  1986cited by this paper
• Cerebral ventricular size in depressed subjects

  1985cited by this paper
• Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides.

  1984cited by this paper
• Glutamate: A Neurotransmitter in Mammalian Brain

  1984cited by this paper
• The evoked release of endogenous amino acids from tissue prisms of human neocortex.

  1983cited by this paper
• Pneumo-Encephalographic and Computerized Axial Tomography Scan Changes in Affective Disorder

  1982cited by this paper
• Mood change following left hemispheric brain injury

  1981cited by this paper
• Postmortem Changes of Amino Compounds in Human and Rat Brain

  1981cited by this paper
• Contemporary Indications for Psychosurgery

  1981cited by this paper
• Computerised tomographic scan changes in manic-depressive illness.

  1981cited by this paper
• Excitatory amino acid transmitters.

  1981cited by this paper
• An electron microscopic study of the types and proportions of neurons in the cortex of the motor and visual areas of the cat and rat.

  1980cited by this paper
• Averaged Evoked Responses in Relation to Cognitive and Affective State of Elderly Psychiatric Patients

  1979cited by this paper
• Ventricular volume in man computed from CAT scans

  1978cited by this paper
• Development of a rating scale for primary depressive illness.

  1967cited by this paper

• Plausible Role of Stem Cell Types for Treating and Understanding the Pathophysiology of Depression

  2023cites this paper
• Brain Imaging of Reward Dysfunction in Unipolar and Bipolar Disorders

  2021cites this paper
• Molecular Imaging of Dopamine and Antipsychotics in Bipolar Disorder

  2021cites this paper
• Resting-State Functional Connectivity in Unipolar Depression

  2021cites this paper
• Effects of Lithium on Brain Structure in Bipolar Disorder

  2021cites this paper
• Magnetic Resonance Spectroscopy Investigations of Bioenergy and Mitochondrial Function in Mood Disorders

  2021cites this paper
• Imaging Glutamatergic and GABAergic Abnormalities in Mood Disorders

  2021cites this paper
• Functional Near-Infrared Spectroscopy Studies in Mood Disorders

  2021cites this paper
• Electrophysiological Biomarkers for Mood Disorders

  2021cites this paper
• fMRI Neurofeedback as Treatment for Depression

  2021cites this paper
• Functional Connectome in Bipolar Disorder

  2021cites this paper
• An Overview of Machine Learning Applications in Mood Disorders

  2021cites this paper
• Neuroimaging Biomarkers in Pediatric Mood Disorders

  2021cites this paper
• Neuroanatomical Findings in Bipolar Disorder

  2021cites this paper
• Neuroanatomical Findings in Unipolar Depression and the Role of the Hippocampus

  2021cites this paper
• Brain Imaging Methods in Mood Disorders

  2021cites this paper
• Magnetoencephalography Studies in Mood Disorders

  2021cites this paper
• Neuroimaging Studies of Effects of Psychotherapy in Depression

  2021cites this paper
• Brain Imaging and the Mechanisms of Antidepressant Action

  2021cites this paper
• Imaging Genetic and Epigenetic Markers in Mood Disorders

  2021cites this paper
• Neuroimaging Brain Inflammation in Mood Disorders

  2021cites this paper
• Clinical overview of NMDA-R antagonists and clinical practice.

  2020cites this paper
• Dysregulation of the Glutamatergic System in Major Depressive Disorder

  2020cites this paper
• Ketamine: The final frontier or another depressing end?

  2020cites this paper
• A comparison of the effect of supplementation and sunlight exposure on serum vitamin D and parathyroid hormone: A systematic review and meta-analysis

  2020cites this paper
• Astrocyte-Conditioned Medium Protects Prefrontal Cortical Neurons from Glutamate-Induced Cell Death by Inhibiting TNF-α Expression

  2019cites this paper
• Anterior Cingulate Cortex Glutamatergic Metabolites and Mood Stabilizers in Euthymic Bipolar I Disorder Patients: A Proton Magnetic Resonance Spectroscopy Study.

  2018cites this paper
• Ketamine: A Promising Rapid-Acting Antidepressant

  2018cites this paper
• Prevalencia, causas y tratamiento de la depresión mayor

  2017cites this paper
• Therapeutic Effect of Astroglia-like Mesenchymal Stem Cells Expressing Glutamate Transporter in a Genetic Rat Model of Depression

  2017cites this paper
• The role of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in depression: central mediators of pathophysiology and antidepressant activity?

  2015cites this paper
• Major depresif bozuklukta prolidaz aktivitesi Prolidase activity in major depressive disorder

  2015cites this paper
• Anterior cingulate Glutamate-Glutamine cycle metabolites are altered in euthymic bipolar I disorder.

  2015cites this paper
• The role of NMDA receptors in the pathophysiology and treatment of mood disorders.

  2014cites this paper
• Dissociation of glutamate and cortical thickness is restricted to regions subserving trait but not state markers in major depressive disorder.

  2014cites this paper
• Glutamate system as target for development of novel antidepressants

  2013cites this paper
• Treatment with tianeptine induces antidepressive-like effects and alters the neurotrophin levels, mitochondrial respiratory chain and cycle Krebs enzymes in the brain of maternally deprived adult rats

  2013cites this paper
• Optimisation of repetitive transcranial magnetic stimulation using electroencephalographic measurements in patients suffering from mood disorders

  2013cites this paper
• Early environments and neurobehavioural programming : therapeutic actions of antidepressants : neurobehavioural programming during development

  2013cites this paper
• Bcl-2 rs956572 Polymorphism is Associated with Increased Anterior Cingulate Cortical Glutamate in Euthymic Bipolar I Disorder

  2013cites this paper
• The action of antidepressants on the glutamate system: regulation of glutamate release and glutamate receptors.

  2013cites this paper
• Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction

  2013cites this paper
• Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders.

  2012cites this paper
• Clinically Significant Drug Interactions with Newer Antidepressants

  2012cites this paper
• Targeting the Glutamatergic System to Treat Major Depressive Disorder

  2012cites this paper
• AVALIAÇÃO DA ASSOCIAÇÃO ENTRE O EFEITO NEUROPROTETOR E ANTIDEPRESSIVO DA ATORVASTATINA EM CAMUNDONGOS

  2012cites this paper
• Association between the C(-1019)G functional polymorphism of the HTR1A gene and impulsivity and subthreshold depression

  2012cites this paper
• Plasma amino acid levels discriminate between control subjects and mildly depressed elderly women.

  2012cites this paper
• The GABAergic deficit hypothesis of major depressive disorder

  2011cites this paper
• EFEITOS COMPORTAMENTAIS E NEUROQUÍMICOS DA ADMINISTRAÇÃO DE CETAMINA E MEMANTINA EM RATOS WISTAR: IMPLICAÇÕES PARA O ENVOLVIMENTO DO SISTEMA GLUTAMATÉRGICO NO TRATAMENTO DA DEPRESSÃO

  2011cites this paper
• Metabolomic Differences in Heart Failure Patients With and Without Major Depression

  2010cites this paper
• Polymorphisms in GRIK4, HTR2A, and FKBP5 Show Interactive Effects in Predicting Remission to Antidepressant Treatment

  2010cites this paper
• Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders.

  2010cites this paper
• Reduced parahippocampal and lateral temporal GABAA-[11C]flumazenil binding in major depression: preliminary results

  2010cites this paper
• Die Bedeutung des glutamatergen Systems für Pathophysiologie und Pharmakotherapie der Depression: präklinische und klinische Daten

  2010cites this paper
• An update on the role of glutamate in the pathophysiology of depression

  2010cites this paper
• Pharmacogenomics of antidepressant drugs.

  2009cites this paper
• Depression and antidepressants: molecular and cellular aspects

  2009cites this paper
• Targeting glial physiology and glutamate cycling in the treatment of depression.

  2009cites this paper
• PESQUISA TRANSLACIONAL EM MEDICINA

  2009cites this paper
• Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders

  2008cites this paper
• Prolonged stress will induce Alzheimer's disease in elderly people by increased release of homocysteic acid.

  2007cites this paper
• The role of the glutamatergic system in the pathophysiology and treatment of mood disorders

  2006cites this paper
• Melancholia: The Diagnosis, Pathophysiology and Treatment of Depressive Illness

  2006cites this paper
• GABA and glutamate systems as therapeutic targets in depression and mood disorders

  2005cites this paper
• Beyond Monoamines: Glutamatergic Function in Mood Disorders

  2005cites this paper
• Glutamate and depression: clinical and preclinical studies.

  2003cites this paper
• Glutamate and Depression

  2003cites this paper
• Clinical Studies Implementing Glutamate Neurotransmission in Mood Disorders

  2003cites this paper
• Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism.

  2002cites this paper
• Chapter 5 Omega-3 fats in depressive disorders and violence: the context of evolution and cardiovascular health

  2002cites this paper
• Advances in brain imaging

  2001cites this paper
• Endogenous sulphur‐containing amino acids: potent agonists at presynaptic metabotropic glutamate autoreceptors in the rat central nervous system

  2001cites this paper
• Neuroimaging studies of mood disorders.

  2000cites this paper
• Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study.

  2000cites this paper
• Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression.

  2000cites this paper
• Prefrontal Cortical‐Amygdalar Metabolism in Major Depression

  1999cites this paper
• Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment‐resistant depression: modulation by treatment with antidepressants and prediction of clinical responsivity

  1998cites this paper
• Homocysteic and homocysteine sulphinic acid exhibit excitotoxicity in organotypic cultures from rat brain

  1998cites this paper
• Plasma and Platelet Amino Acid Concentrations in Patients Affected by Major Depression and under Fluvoxamine Treatment

  1998cites this paper
• The frontal lobes and neurosurgery for psychiatric disorders

  1997cites this paper
• The neurotransmitter candidature of sulphur-containing excitatory amino acids in the mammalian central nervous system.

  1996cites this paper
• Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression.

  1995cites this paper
• The effect of 5-HT1A receptor ligands in a chronic mild stress model of depression.

  1995cites this paper
• Excitatory amino acids: implications for psychiatric disorders research.

  1994cites this paper
• Neurochemical similarities in depression and pain, with special emphasis on serotonin

  1994cites this paper
• Are neuropsychiatric manifestations of folate, cobalamin and pyridoxine deficiency mediated through imbalances in excitatory sulfur amino acids?

  1994cites this paper
• Preliminary neurochemical findings in non-Alzheimer dementia due to lobar atrophy.

  1993cites this paper
• Plasma and platelet excitatory amino acids in psychiatric disorders.

  1993cites this paper
• NMDA glutamatergic receptors, labelled with [3H]MK-801, in brain samples from drug-free depressed suicides.

  1993cites this paper
• Neuroanatomic Substrates of Depression in the Elderly

  1993cites this paper
• Antemortem measurements of neurotransmission: possible implications for pharmacotherapy of Alzheimer's disease and depression.

  1993cites this paper
• Is depression a neurologic disease?

  1993cites this paper
• Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agents.

  1993cites this paper
• Calcium-independent release of amino acid neurotransmitters: fact or artifact?

  1992cites this paper
• 5-Hydroxytryptamine1A but not 5-hydroxytryptamine2 receptors are enriched on neocortical pyramidal neurones destroyed by intrastriatal volkensin.

  1992cites this paper
• Effect of Psychotropic Drugs on Excitatory Amino Acids in Patients Undergoing Psychosurgery for Depression

  1992cites this paper
• Alternative approaches to the discovery of novel antipsychotic agents.

  1992cites this paper
• Evidence of glutamatergic deficiency in schizophrenia.

  1991cites this paper
• Clinical correlations of the neurobiological changes of aging.

  1990cites this paper